Stanley Laman Group, Ltd. Acadia Pharmaceuticals Inc Transaction History

Stanley Laman Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 09, 2018	SELL	$15.07 - $22.34 $210,166 - $311,553	-13,946 Closed	0 $0
Q1 2018 May 01, 2018	SELL	$22.47 - $32.33 $6.45 Million - $9.28 Million	-287,159 Reduced 95.37%	13,946 $313,000
Q4 2017 Feb 09, 2018	BUY	$26.84 - $39.14 $4.22 Million - $6.15 Million	157,229 Added 109.28%	301,105 $9.07 Million
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $4.24 Million - $5.52 Million	143,876	143,876 $5.42 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.